Abstract

Abstract Submission

The Scientific Program Committee invites clinicians and researchers in general pediatrics and pediatric allergy-immunology to submit abstracts for oral or poster presentations, and/or for inclusion in the conference abstract book. Submissions may include clinical studies, basic or translational research, case series, management strategies, or clinical practice insights related to pediatric care.

Please read the Abstract Submission Guidelines carefully before submitting. All abstracts must be submitted electronically via the official Congress website. Submissions by post, fax, or email WILL NOT BE ACCEPTED.

• A

  Key Date

  Abstract submission deadline: August 15, 2025

• B

  Submission Notes
  • Accepted abstracts will be scheduled for presentation in either thematic Poster Sessions or Oral Presentation Sessions. Abstracts not selected for presentation may still be included in the official abstract book.
  • All presenting authors of accepted abstracts are required to register for the Congress. They are responsible for their own presentation materials, travel, accommodation, and any other expenses related to attendance.
  • It is the author’s responsibility to ensure that abstracts are written clearly, in grammatically correct English, and contain accurate scientific content. Abstracts lacking data or written in poor English will not be considered.
  • Detailed presentation instructions will be sent to all presenting authors upon acceptance of their abstract(s), closer to the Congress date.
  • A confirmation of receipt will be sent automatically to the presenting author upon submission. Notification of acceptance or rejection will follow after peer review. All communication regarding the abstract, including its status, session assignment, date, and time of presentation, will be sent to the email address provided during submission.

• C

  Abstract Guidelines
  • Abstracts must be written and presented in English.
  • All abstracts must be submitted online via the official Congress submission portal.
  • You must be registered for the Congress in order to submit an abstract.
  • Abstracts must contain original data and comply with international ethical standards.
  • Case reports may be considered if they present significant findings and include appropriate statistical and analytical methods.
  • Abstracts that have been previously presented or published may be submitted; however, they will not be republished on the Congress website.
  • Do not include the abstract title, author names, or institutions in the body of the abstract text.
  • Standard abbreviations may be used; any non-standard or uncommon abbreviations should be spelled out in full upon first mention, followed by the abbreviation in parentheses.
  • Use generic (non-proprietary) drug names in lowercase upon first mention. Trade names are not allowed.
  • Multiple abstract submissions by the same author are permitted.

• D

  Abstract Topic Categories
  • Allergens & Immunotherapy
  • Allergic Rhinoconjunctivitis
  • Allergy Prevention, Diagnosis, and Treatment
  • Anaphylaxis
  • Asthma
  • Atopic Dermatitis
  • Basic & Clinical Immunology
  • Climate Change and Allergy
  • Drug Allergy
  • Food Allergy
  • Inborn Errors of Immunity
  • Urticaria & Angioedema
  • Miscellaneous

• E

  Abstract Structure
  Research Report Abstracts

  Please structure your abstract using the following subheadings in bold:

  • Background: Briefly state the purpose and rationale of the study.
  • Methods: Outline the study design, methodology, and, if applicable, patient selection criteria.
  • Results: Summarize the key findings with appropriate statistical data.
  • Conclusions: Present the main conclusions derived from the results. Avoid vague statements such as "Results will be discussed" or "Data will be presented."
  Case Report Abstracts

  Please structure your case report abstract using the following subheadings in bold:

  • Background: Provide a brief overview of the clinical relevance and rationale for reporting the case. Highlight the novelty, significance, or unusual nature of the case in the context of existing medical knowledge.
  • Case/Cases: Present the case in a clear and concise manner. Include relevant patient demographics (e.g., age, sex), clinical history, diagnostic work-up, management, and outcomes. Emphasize key findings and their relevance to the diagnosis or treatment approach. For multiple cases, briefly describe each case while focusing on shared insights or differences.
  • Conclusion: Summarize the clinical lessons, implications for practice, or broader relevance of the case. Avoid vague statements such as “The case will be discussed” or “Further data will be presented.”
  • Keywords: Include 3–5 keywords that reflect the core topics of the case report. These will help index the abstract and improve its discoverability.
  • The abstract text is limited to 300 words.
  • Tables, figures, and graphs are not permitted within the abstract text.
  • Abstracts that do not follow this format may be rejected.

• F

  Affiliations

  List all affiliations including department, institution, city, and country. If there are multiple affiliations, list each one separately and match them using superscript numbers as follows:

  • Department, University, City, Country
  • Institution, City, Country
  • Company, City, Country

• G

  Consent to Publish

  If the abstract contains identifiable patient information, authors are required to obtain prior consent before submission. Please confirm during submission whether consent has been obtained or is not required.

• H

  Abstract Revisions

  Revisions can be made through the abstract submission system until August 15, 2025. No further changes will be accepted after this date.

• I

  Notification of Acceptance

  Acceptance notifications will be sent by August 31, 2025, to the Presenting Author via the email address provided during submission. This communication will include the abstract status, presentation type, date, and time.

• J

  Publication of Abstracts

  Accepted abstracts will be published online as part of the official Congress proceedings.

• K

  Presenter Attendance Policy

  APAPARI reserves the right to decline future abstract submissions from authors who fail to attend and present their accepted work during the scheduled session without prior notice.